| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.286.6.688 |
| P698 | PubMed publication ID | 11495618 |
| P50 | author | Kathleen A. Shutt | Q39920417 |
| Nancy E. Messonnier | Q88978852 | ||
| Bradley A. Perkins | Q125708450 | ||
| P2093 | author name string | M Collins | |
| M G Bruce | |||
| J M Capparella | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meningococcal disease | Q890785 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 688-693 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Risk factors for meningococcal disease in college students | |
| P478 | volume | 286 |
| Q90627325 | A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States |
| Q41271773 | A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, France, February to May 2017. |
| Q38775024 | An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence |
| Q35901353 | Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research |
| Q37590858 | Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis |
| Q49377063 | Challenges and opportunities for Meningococcal vaccination in the developing world |
| Q30362049 | College Health Surveillance Network: Epidemiology and Health Care Utilization of College Students at US 4-Year Universities |
| Q36288122 | College and university compliance with a required meningococcal vaccination law. |
| Q80747275 | Combined administration of serogroup B meningococcal vaccine and conjugated serogroup C meningococcal vaccine is safe and immunogenic in college students |
| Q26741975 | Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements |
| Q34623334 | Development of vaccines against meningococcal disease |
| Q26775667 | Enter B and W: two new meningococcal vaccine programmes launched |
| Q92193207 | Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review |
| Q33648635 | Epidemiological profile of meningococcal disease in the United States |
| Q37761235 | Epidemiology and meningococcal serogroup distribution in the United States |
| Q36600323 | Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135. |
| Q89771036 | Experts' opinion for improving global adolescent vaccination rates: a call to action |
| Q36206141 | First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak |
| Q44677055 | Global epidemiology of meningococcal disease. |
| Q33168866 | Harnessing Syndromic Surveillance Emergency Department Data to Monitor Health Impacts During the 2015 Special Olympics World Games |
| Q30249427 | History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention |
| Q34476711 | Immunizations for high-risk populations |
| Q38867474 | Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults |
| Q55303290 | Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature. |
| Q27023516 | Importance of circulating antibodies in protection against meningococcal disease |
| Q36934725 | Infections in confined spaces: cruise ships, military barracks, and college dormitories |
| Q58712935 | Interconnected clusters of invasive meningococcal disease due to serogroup C ST-11 (cc11), involving bisexuals and men who have sex with men, with discos and gay-venues hotspots of transmission, Tuscany, Italy, 2015 to 2016 |
| Q38028992 | MenACWY-TT vaccine for active immunization against invasive meningococcal disease |
| Q26752993 | Meningococcal Vaccinations |
| Q41600060 | Meningococcal carriage among Georgia and Maryland high school students |
| Q47102654 | Meningococcal carriage among a university student population - United States, 2015. |
| Q89367696 | Meningococcal disease burden and transmission in crowded settings and mass gatherings other than Hajj/Umrah: A systematic review |
| Q57055712 | Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination |
| Q35194824 | Meningococcal glycoconjugate vaccines. |
| Q36687501 | Meningococcal meningitis prevention programs for college students: a review of the literature |
| Q34979682 | Meningococcal vaccine use in college students |
| Q80511370 | Meningococcal vaccines |
| Q46628094 | Modifiable risk factors for invasive meningococcal disease during an Edmonton, Alberta outbreak, 1999-2002. |
| Q30235072 | Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States |
| Q99410749 | Neisseria meningitidis carriage and risk factors among teenagers in Suizhou city in China |
| Q35060543 | Personal and household hygiene, environmental contamination, and health in undergraduate residence halls in New York City, 2011 |
| Q36934373 | Prevention of infectious diseases in athletes |
| Q24537338 | Prospects for vaccine prevention of meningococcal infection |
| Q37461347 | Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy |
| Q57180910 | Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies |
| Q36170833 | Risk and prevention of meningococcal disease among education workers: A review |
| Q34407928 | Risk and protective factors for meningococcal disease in adolescents: matched cohort study |
| Q47265736 | Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine. |
| Q36170714 | Should university students be vaccinated against meningococcal disease in Canada? |
| Q37106468 | State-based surveillance to determine trends in meningococcal disease |
| Q44622464 | The Risk of Meningococcal Disease in Travelers and Current Recommendations for Prevention |
| Q37706585 | The epidemiology of meningococcal disease and the impact of vaccines |
| Q35144175 | The immunopathogenesis of meningococcal disease |
| Q36221304 | Trends in meningococcal disease in the United States military, 1971-2010. |
| Q36932726 | US college and university student health screening requirements for tuberculosis and vaccine-preventable diseases, 2012. |
| Q41932534 | Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease |
| Q64127980 | Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis |
| Q38538836 | Vaccines for prevention of group B meningococcal disease: Not your father's vaccines |
| Q37915659 | What is the evidence for giving chemoprophylaxis to children or students attending the same preschool, school or college as a case of meningococcal disease? |
| Q89668848 | [Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy] |
Search more.